Project Grant HT94252410030
Award Date
1/1/24
Completion Date
12/31/25
Dollars Obligated
$324K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
The Johns Hopkins University was awarded a $493,829 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research titled "PRETARGETING BACTERIAL THERAPY OF HER2+ BREAST CANCER" from June 1, 2023 through May 31, 2026. Through this award, The Johns Hopkins University will conduct applied biomedical studies to investigate medical solutions for breast cancer on the battlefield....
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $2,728,777.00 in funding to the University of Virginia to conduct research on "NEUROACTIVE STEROID BIOSYNTHESIS AND DYNAMIC GABAA RECEPTOR RECONFIGURATION IN POSTPARTUM DEPRESSION". The award period runs from May 1, 2025 to April 30, 2029, supporting advanced biomedical research into the neurological mechanisms underlying postpartum depression. This...
The U.S. Department of Defense's Defense Health Agency awarded a $1,738,924 Project Grant to The Johns Hopkins University to conduct research on "Proteomics of Atrioventricular Septal Defect in Down Syndrome" from September 1, 2024 through August 31, 2028. This research, funded under the Military Medical Research and Development program (CFDA 12.420), aims to advance scientific understanding and treatment of this condition impacting military members, veterans, and their families. The...
The Johns Hopkins University has been awarded a $1,099,238 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) with a period of performance from September 1, 2024 to August 31, 2026. This grant will support investigator-initiated biomedical research projects across multiple medical disciplines to improve health outcomes for military service members, veterans, and the broader public. The award enables Johns Hopkins to conduct...
This $1,637,500 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Johns Hopkins University to target specific PARP1 inhibition for breast cancer treatment. The award, which began on July 1, 2024 and will be completed by June 30, 2027, will enable the university to conduct innovative scientific studies ranging from basic laboratory research to advanced clinical trials focused on improving...
The Johns Hopkins University received a three-year, $651,158 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support the university's research into early assessment of treatment response in breast cancer patients undergoing neoadjuvant therapy using an automated liquid biopsy-breast cancer methylation assay. The Military Medical Research and Development program aims to transform military...
This $1,536,075 federal Project Grant awarded by the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development program) supports proteomics research on atrioventricular septal defect in Down syndrome at The Johns Hopkins University. The award period runs from September 1, 2024 to August 31, 2028. The funding will allow Johns Hopkins to conduct basic, translational, and clinical research to improve understanding and treatment of this condition, which is a priority area for...
The Johns Hopkins University received a $248,356 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Cardiometabolic Comorbidity and Outcomes in Multiple Sclerosis: A Polygenic Risk Score Approach". The award period runs from September 1, 2023 to August 31, 2025. The project aims to investigate medical solutions for the battlefield through innovative and impactful biomedical research....
The Johns Hopkins University was awarded a $647,632 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. Through the support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform health...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $855,728 to The Johns Hopkins University to identify abnormally regulated lipid pathways in human motor neuron and fly models, with the goal of developing a new pharmacological drug candidate. The award period runs from Sep 1, 2024 to Aug 31, 2026. As a leading research university, Johns Hopkins has a strong track record of federal grant...